News
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
18hon MSN
The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
Novo Nordisk A/S’s decision to stop making insulin pens will narrow treatment options for children with diabetes unless ...
1don MSN
CEO Lars Jørgensen is stepping down from his post after eight years in the role, during which he lead the company to an ...
Much has been learned about GLP-1s over many years, but little is understood about why the degree of response to them varies ...
Clinical Trials Arena on MSN4d
Novo Nordisk’s Sogroya matches Norditropin in children’s growth disordersThe Danish multinational said that Sogroya improved the yearly growth rate in pre-pubertal children born small for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback